美国伯乐 BIO-RAD  
Bio-Rad公司总部设在美国加里福尼亚州的Hercules，在全球有30多家全资子公司，服务于全球超过85,000家科研院所，生物技术和制药公司，和临床实验室。
　公司自1952年成立以来，在50多年中为临床诊断和生命科学研究市场提供了广泛的新型产品和服务，始终居于科学发现的中心地位。Bio-Rad现今利用多种技术制造并生产了几千种产品，这些技术包括蛋白质组学、生物信息学、电泳、成像、免疫测定、层析、微生物学和基因转移。根据产品的不同，公司下设三大部门，它们是生命科学部，临床诊断部和工业材料部，产品种类达6000余种。主要产品有蛋白组研究产品、层析仪与填料、蛋白质和核酸电泳产品、基因枪与电穿孔仪、定量基因扩增仪、图像分析系统、激光共聚焦扫描显微镜、酶标仪和洗板机系列、食品检测仪器与试剂、糖化血红蛋白检测系列产品、质控系统、毒物检测产品、血液病毒检测产品等。

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.

Life Science Group:
Bio-Rad's Life Science Group develops, manufactures, and markets a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The group ranks among the top 5 life science companies worldwide, and maintains a solid reputation for quality, innovation, and commitment to its customers. Bio-Rad's life science products are based on technologies used to separate, purify, analyze, identify, and amplify biological materials such as proteins and nucleic acids. Some of these technologies include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, bioinformatics, protein function analysis, transfection, amplification, and real-time PCR. Researchers in laboratories throughout the world rely on Bio-Rad's products.

Clinical Diagnostics Group:
Clinical Diagnostics develops, manufactures, sells, and supports a large portfolio of products for medical screening and diagnostics. Bio-Rad is the leading specialty diagnostics company in the world and its products are recognized as the gold standard for diabetes monitoring and quality control (QC) systems. The company is also well known for its blood virus testing and detection, blood typing, autoimmune and genetic disorders testing, and internet-based software products. Bio-Rad's clinical diagnostics products incorporate a broad range of technologies used to detect, identify, and quantify substances in bodily fluids and tissues. The results are used as aids to support medical diagnosis, detection, evaluation, and the 
Bio-Rad was founded in 1952 by David and Alice Schwartz, who remain actively involved in the company today. David Schwartz is Chairman of the Board and Alice is a director. Their son Norman Schwartz, with the company since 1974, is CEO and president.

The name "Bio-Rad" is based on the words "biochemicals and radiochemicals," which described the company's first offerings. However, instead of calling the company "Biochemical-Radiochemical Laboratories," the founders shortened it to simply Bio-Rad Laboratories.

For more than 50 years, Bio-Rad has retained the entrepreneurial spirit of its early days. Its founders launched the company in a Quonset hut in West Berkeley, California, and developed their first product, tobacco mosaic virus (TMV). Preparing TMV was a laborious task and the founders believed that providing it in a ready-to-use format would save scientists valuable time and effort, allowing them to focus on their research.

Although TMV was not the success envisioned, the seed was planted and Bio-Rad began its charter to accelerate scientific discovery processes by providing products and tools for researchers.

In the 1950s, Bio-Rad introduced the first analytical grade ion exchange resins for laboratory research applications, launching the company's Life Science Group. In 1957 Bio-Rad incorporated and in 1958 relocated its headquarters to Richmond, California. By 1966 the company sold its stock to the public and expanded internationally with its first overseas office in Germany.

Bio-Rad's early success with ion exchange resin products led to inquiries from physicians and hospital pathologists seeking a more reliable method for determining thyroid function. In conjunction with the medical community, Bio-Rad introduced the T-4 (thyroxine) thyroid test in 1967, the first commercially available test to accurately determine thyroid function. By the early 1970s Bio-Rad had developed tests for a variety of other medical conditions including cardiovascular disease, lead poisoning, and anemia, paving the way for the formation of the company's Clinical Diagnostics Group.

During the 1970s Bio-Rad entered the electrophoresis market with reagents, systems, and equipment, and today the company is a worldwide market leader in electrophoresis products. Bio-Rad's advancements in electrophoresis put the company at the forefront of unlocking the secrets of life contained in DNA and determining how genetic information translates into living organisms.

Over the years, Bio-Rad has evolved into a global enterprise that manufactures and distributes a broad range of products around the world. In 1975 Bio-Rad entered the quality controls market with the acquisition of Environmental Chemical Specialties, and today Bio-Rad is the number one supplier of quality controls worldwide.

In 1997 Bio-Rad launched its Biotechnology Explorer science educational program, giving high school and college students the opportunity to learn how real-world methods and applications work on instruments used in laboratories today.

The 1999 acquisition of Pasteur Sanofi Diagnostics, based in France, further broadened Bio-Rad's offerings with products for blood virus testing (HIV and hepatitis), microbiology and autoimmunity testing products, and the notable introduction of its bovine spongiform encephalopathy (BSE or "mad cow") test in 2000.

Today, Bio-Rad products are used in hospitals, universities, major research institutions, biotechnology companies, reference laboratories, pharmaceutical firms, and classrooms around the world. Bio-Rad's key competencies include separation, purification, and analysis, and the company is a leader in electrophoresis, protein assays, gel image analysis, quality controls, diabetes monitoring, autoimmune testing, blood typing, and BSE and chronic wasting disease testing.

The company's open-door style of leadership and entrepreneurial spirit inspires its employees, who are encouraged to develop new ideas. As a result Bio-Rad continues to thrive and plays a leading role in the advancement of scientific discovery, helping people live longer, healthier lives.